Astex, MDI announce collaboration to identify neurodegenerative disease drugs
The partnership will combine the research capabilities of Dr Emyr Lloyd-Evans & Dr Helen Waller-Evans in lysosomal biology, MDI’s drug discovery capabilities and the fragment-based drug discovery platform